Feedback / Questions
ALE.C04 - Alentis Therap
ALE.F02 - Alentis Therap
https://www.businesswire.com/news/home/20230108005023/en/Positive-Results-from-Single-Ascending-Dose-Phase-1-Study-of-ALE.F02-Targeting-Claudin-1
Jan 9, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next